Assure, a tech startup that allowed investors to pool together funds to make private investments, suddenly shut down. They took cash-up-front to manage these funds (called SPVs) for their lifetime. Now the cash is gone and they’re dumping the legal […]
Dan Shipper trained a chatbot on transcripts of the Huberman Lab podcast. Now he can interrogate it as if it were (a slightly bumbling version of) Andrew Huberman himself. “It’ll be a big change for the way content is produced […]
A running list of excellent ways to bypass the safeguards that prevent ChatGPT from behaving badly. Some are already patched. But human innovation knows no limits, so on with the cat-vs-mouse games! | learn more
My friend and favorite Austin real estate broker Soud Twal’s latest listing: “Located between Lake Austin and Lake Travis, the nearly $7 million contemporary, white-stucco home is a 30-minute drive from downtown” | learn more
“Chicago isn’t necessarily synonymous with its spot as a biopharma hotbed – however, due to new investments, governmental support, collaborations and prominent academic institutions, this is changing.” | learn more
I feel a bit weird sharing this link, but hey, I think it is interesting. It’s written for an audience of women with autism, presumably a mild version. The author looks analytically at the social choices young women make, and […]
“It was determined that the bottom 80% of men (in terms of attractiveness) are competing for the bottom 22% of women and the top 78% of women are competing for the top 20% of men. The Gini coefficient for the […]
I loved this explanation of the nuclear energy market and the technology advances nearing commercialization. “For the first time, this generation of reactors isn’t 100% government-funded and instead built by venture-backed startups.” | learn more
“Many in the 18th c. who thought democracy was absurd rejected it because they disagreed with this thesis, believing that the majority of people (even of white men) were not educable, i.e. that even with educational resources most people were […]
Most of us are familiar with the annual flu vaccine that targets a few strains that are expected to be most prevalent. “But what is particularly unique, and potentially controversial, about this new 20-strain mRNA vaccine is its targeting of […]